GSTM1 and Hyperbilirubinemia: Subsequent monitoring on November 17th, 2023, demonstrated a Hb concentration of 53g/L, accompanied by significant hyperbilirubinemia (TBIL: 74.3μmol/L, IBIL: 42.3μmol/L, DBIL: 32.0μmol/L).